Table 3.

Spinal cord doses in 31 patients who developed Lhermitte’s sign

	Total dose,	Spinal cord	Location of
Patient ID	Gy	Dmax Gy (%)	Dmax	Cord V105%, cm3
1	30.6	33.04 (108)	T4–T5	3
2	30.6	28.51 (93)	—	0
3	30.6	33.98 (111)	T3	2.26
4	30.6	29.1 (95)	—	0
5	30.6	31.84 (104)	T5–T6	0
6	30.6	35.81 (117)	T3–T8	14.6
7	30.6	31.02 (101)	—	0
8	30.6	30.10 (98)	—	0
9	30.6	29.93 (98)	—	0
10	30.6	34.66 (113)	T5	0.5
11	30.6	30.85 (101)	—	0
12	30.6	31.96 (104)	—	0
13	30.6	28.06 (92)	—	0
14	30.6	30.94 (101)	—	0
15	30.6	34.67 (113)	T4–T7	1.1
16	30.6	30.01 (98)	—	0
17	30.6	32.18 (105)	T9	0
18	29.75	31.19 (105)	—	0
19	30.6	31.72 (104)	—	0
20	30.6	33.12 (108)	T4	0.8
21	30.6	33.06 (108)	T4	1.3
22	30.6	37.23 (105)	—	0
23	30.6	38.78 (108)	T6	0.02
24	30.6	36.21 (101)	—	0
25	37.4	39.34 (105)	—	0
26	39.6	34.13 (109)	T1-T2; T5; T8	0.8
27	41.4	38.69 (93)	—	0
28	42.0	31.02 (74)	—	0
29	46.6	39.40 (85)	—	0
30	41.4	43.51 (105)	—	0
31	36.0	35.48 (99)	—	0

D max = maximum point dose